News & Alerts
-
Aug- 2024 -27 August
How Pharmacovigilance Helps in Detection of Rare Side Effects
The effectiveness and safety of drugs are accessed through pharmacovigilance to ensure their safety while making sure the manufacturers are…
Read More » -
17 August
How Automatic Pharmacy Dispensers Work: Revolutionizing Medication Safety and Efficiency
The healthcare industry has witnessed significant advancements in technology over the years, with one of the most remarkable innovations being…
Read More » -
Jul- 2024 -4 July
Study Links Wegovy and Ozempic to Sight-Threatening Eye Disorder
A recent study has highlighted a concerning potential side effect of semaglutide, the active ingredient in Novo Nordisk’s popular weight-loss…
Read More » -
Jun- 2024 -26 June
Glenmark Pharmaceuticals Recalls Potassium Chloride Extended-Release Capsules Due to Failed Dissolution
Glenmark Pharmaceuticals Inc., USA, based in Mahwah, NJ, has announced a voluntary recall of 114 batches of their Potassium Chloride…
Read More » -
26 June
Diabetes Test Less Reliable In Black Patients
The discovery of a genetic variation common among people of African ancestry, known as G6PD deficiency (G6PDdef), has significant implications…
Read More » -
19 June
Chinese Police Probe Drug-Related Money Laundering Operation After U.S. Tip
Chinese police are investigating a case of illegal foreign exchange activity and money laundering following tip-offs from the United States,…
Read More » -
18 June
Roche Partners with Ascidian Therapeutics to Develop Gene Therapies
June 18, 2024 – Swiss pharmaceutical giant Roche has announced a partnership with Boston-based biotech startup Ascidian Therapeutics to develop…
Read More » -
18 June
FDA Approves Merck’s New Pneumococcal Vaccine for Adults
June 18, 2024 – The U.S. Food and Drug Administration (FDA) has approved Merck & Co Inc’s latest pneumococcal vaccine,…
Read More » -
18 June
FDA Places Zentalis’ Cancer Drug Studies on Partial Hold After Patient Deaths
June 18, 2024 – The U.S. Food and Drug Administration (FDA) has placed three studies of Zentalis Pharmaceuticals’ cancer drug,…
Read More » -
15 June
Ascentage Pharma and Takeda Sign $1.3 Billion Global Licensing Agreement for Cancer Drug
Ascentage Pharma, a leading global biopharmaceutical company, has entered into an option agreement with Takeda, a prominent global biopharmaceutical firm.…
Read More »
